These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 22740770)

  • 61. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.
    Dunn KC; Aotaki-Keen AE; Putkey FR; Hjelmeland LM
    Exp Eye Res; 1996 Feb; 62(2):155-69. PubMed ID: 8698076
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distribution of annexin I during non-pathogen or pathogen phagocytosis by confocal imaging and immunogold electron microscopy.
    Harricane MC; Caron E; Porte F; Liautard JP
    Cell Biol Int; 1996 Mar; 20(3):193-203. PubMed ID: 8673068
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I.
    Sakamoto T; Repasky WT; Uchida K; Hirata A; Hirata F
    Biochem Biophys Res Commun; 1996 Mar; 220(3):643-7. PubMed ID: 8607818
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms.
    Liversidge J; McKay D; Mullen G; Forrester JV
    Cell Immunol; 1993 Jul; 149(2):315-30. PubMed ID: 8330312
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Congenital toxoplasmic retinochoroiditis in a mouse model.
    Hay J; Lee WR; Dutton GN; Hutchison WM; Siim JC
    Ann Trop Med Parasitol; 1984 Apr; 78(2):109-16. PubMed ID: 6742924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids.
    Flower RJ
    Br J Pharmacol; 1988 Aug; 94(4):987-1015. PubMed ID: 2974738
    [No Abstract]   [Full Text] [Related]  

  • 67. Allergic and immunologic disorders of the eye.
    Bielory L; Frohman LP
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):1-15. PubMed ID: 1730829
    [No Abstract]   [Full Text] [Related]  

  • 68. The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis.
    Mimura KK; Tedesco RC; Calabrese KS; Gil CD; Oliani SM
    Mol Vis; 2012; 18():1583-93. PubMed ID: 22740770
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathogenesis of ocular toxoplasmosis.
    Smith JR; Ashander LM; Arruda SL; Cordeiro CA; Lie S; Rochet E; Belfort R; Furtado JM
    Prog Retin Eye Res; 2021 Mar; 81():100882. PubMed ID: 32717377
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New advances in immune mechanism and treatment during ocular toxoplasmosis.
    Chen Z; Cheng S; Chen X; Zhang Z; Du Y
    Front Immunol; 2024; 15():1403025. PubMed ID: 38799473
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Annexin A1 in the nervous and ocular systems.
    Wang A; Zhang H; Li X; Zhao Y
    Neural Regen Res; 2024 Mar; 19(3):591-597. PubMed ID: 37721289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Toward a better understanding of human eye disease insights from the zebrafish, Danio rerio.
    Bibliowicz J; Tittle RK; Gross JM
    Prog Mol Biol Transl Sci; 2011; 100():287-330. PubMed ID: 21377629
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.